HPLC + MS
Independently tested for identity and purity
NP-SELANK-062426-01
Jul 20, 2026
99.15%
View Certificate of Analysis
CAS# 129954-34-3
Also Known As TP-7
Sequence TKPRPGP
Class Synthetic Peptide
Form Lyophilized Powder
Receptor Target
Receptor Target
Pathway
Selank (TP-7, CAS# 129954-34-3) is a synthetic heptapeptide analogue of the endogenous immunopeptide tuftsin (TKPR), developed at the Institute of Molecular Genetics of the Russian Academy of Sciences. The compound is characterised by binding activity at GABA-A receptors and interactions with serotonergic and neurotrophic signalling pathways. Supplied by NexPept as a lyophilized powder for in vitro laboratory research use. This compound has not been authorized by Health Canada for any therapeutic, clinical, or human use.
Molecular Profile
CAS#, sequence, formula, molecular weight, analytical data
CAS#, sequence, formula, molecular weight, analytical data
| Property | Value |
|---|---|
| CAS Number | 129954-34-3 |
| Research Designation | TP-7 |
| Sequence | Thr-Lys-Pro-Arg-Pro-Gly-Pro (TKPRPGP) |
| Parent Scaffold | Tuftsin (TKPR) analogue with C-terminal Pro-Gly-Pro extension |
| Molecular Formula | C₃₃H₅₇N₁₁O₉ |
| Molecular Weight | ~751.9 Da |
| Compound Class | Synthetic heptapeptide — tuftsin analogue |
| Receptor Targets | GABA-A receptor, serotonergic system, TrkB/BDNF pathway |
| Physical Form | Lyophilized powder |
| Analytical Method | High-Performance Liquid Chromatography (HPLC) + Mass Spectrometry (MS) |
| Appearance | White to off-white lyophilized solid |
In Vitro Research Context
Receptor pharmacology — laboratory use only
Receptor pharmacology — laboratory use only
GABAergic receptor — chloride channel modulation studies
Serotonergic pathway — reuptake and MAO-A modulation research
Neurotrophic signalling — BDNF expression and TrkB pathway studies
Selank is studied in preclinical in vitro settings as a pharmacological tool for investigating GABAergic receptor modulation, serotonergic pathway interactions, and neurotrophic signalling. Research applications include receptor binding assays, electrophysiological studies of GABA-A chloride currents, serotonin reuptake assays, and BDNF mRNA expression analysis. As a tuftsin-derived compound with a stabilising Pro-Gly-Pro C-terminal extension, it is used in controlled laboratory environments to study peptide-receptor interactions and downstream signalling mechanisms.
Research context: Selank is an investigational compound studied in scientific research involving GABAergic, serotonergic, and neurotrophic signalling pathways. Research into this compound remains ongoing. It has not been authorized by Health Canada for human or veterinary use.
Available Formats
10mg — lyophilized powder
10mg — lyophilized powder
| Format | Net Quantity | Physical Form |
|---|---|---|
| Selank 10mg | 10 mg / vial | Lyophilized powder |
Sourced from a verified batch. Quantity for use should be determined based on your specific in vitro research protocol by qualified research personnel.
Laboratory Storage
Controlled storage conditions for lyophilized material
Controlled storage conditions for lyophilized material
Store sealed lyophilized material under controlled laboratory conditions in accordance with validated institutional SOPs and applicable technical documentation. Protect from moisture and light. Handling conditions should be established by qualified research personnel in accordance with the specific experimental protocol.
Note: No preparation, reconstitution, or administration instructions are provided. This compound is supplied for in vitro laboratory research use only. All handling must be conducted by qualified personnel following institutional safety protocols.
Research Literature
Scientific references & related resources
Scientific references & related resources
PubMed — Selank / TP-7 — peer-reviewed scientific literature on this compound
Selank 10mg — NexPept — compound overview and in vitro research context
Research Peptides in Canada — sourcing and research context for Canadian laboratories
What Are Research Peptides? — peptide classification and in vitro research context
This product is supplied exclusively for in vitro laboratory and non-clinical research use by qualified research personnel. It is not authorized by Health Canada for human or veterinary use. No therapeutic, clinical, or health claims are made.
This material must not be administered to humans or animals. No dosage, preparation, reconstitution, or administration instructions are provided or implied. All handling and use must be conducted by qualified personnel in accordance with applicable institutional policies and legal requirements.
Be the first to review “SELANK 10MG”
Related products
Reviews
There are no reviews yet.